Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people begin to notice weight loss on Wegovy within the first four to eight weeks, though the amount lost in those early weeks is modest. The starting dose of 0.25mg is designed to help your body adjust, not to drive rapid fat loss. Real, sustained loss builds over months as the dose increases under your prescriber's direction. Wegovy is a prescription-only medicine; a clinician assesses whether it's suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's genuinely frustrating to inject a medicine once a week and barely see the number on the scales move for the first month. That frustration is understandable, and it's the thing our prescribers hear most often in those early weeks. The common assumption is that slow initial loss means the treatment isn't working. It doesn't. It means the dose is doing exactly what it's supposed to do: settling your system gently before the therapeutic work begins.
Wegovy's starting dose of 0.25mg is a tolerability step. Its job is to reduce the risk of nausea and other gastrointestinal discomfort, not to suppress appetite to its full extent. At that dose, many people notice a slight reduction in hunger, and some see a small dip in weight. Others notice nothing at all on the scales. Both responses are normal. The medicine isn't broken. The titration schedule, designed by your prescriber, is doing its job.
Weight loss on semaglutide is a gradual process that accelerates as the dose increases toward the 2.4mg maintenance level, typically reached after around five months. If you want to understand how long before weight loss on Wegovy begins to build meaningfully, our guide to what happens after your first Wegovy shot covers the early weeks in more detail. The short version: patience in month one is not wasted effort.
Between roughly the fourth and twelfth week of treatment, most people start to see more consistent movement. This coincides with the first and second dose increases, typically to 0.5mg and then 1.0mg. Appetite suppression becomes more noticeable. Portion sizes fall. The pull toward high-calorie foods often weakens. For many people, this is when they first feel that the medicine is genuinely changing something.
The Wegovy overview page covers how semaglutide works as a GLP-1 receptor agonist, slowing gastric emptying and signalling fullness to the brain, but the practical upshot is this: less hunger usually means less eating, and that deficit accumulates. If you're wondering how fast you start losing weight on Wegovy, the pace varies by individual but losses of roughly one to two kilograms per month are common in this middle phase for people who are also making dietary changes. That may feel slower than you hoped. Over six months it adds up considerably.
One important context: the STEP 1 trial, published in the New England Journal of Medicine, found an average weight reduction of around 15% over 68 weeks at the 2.4mg dose. That headline figure was built over more than a year, not in the first few weeks. The people who saw the largest total losses were the ones who stayed consistent through the slower early phase.
The fastest period of weight loss for most people on Wegovy tends to fall between months three and nine, once the full maintenance dose is established and the body has adapted to it. After that, the rate often plateaus. This is not a sign of failure. The medicine is still working; the body's energy systems adapt over time, which is why long-term support, lifestyle change and regular clinical review all matter.
A few things can slow progress at any stage: inconsistent adherence to the dose schedule, insufficient dietary change, very low physical activity, or an underlying health condition affecting metabolism. Our page on how quickly you start losing weight on Wegovy goes deeper into individual variation and what influences the pace of results. Practically speaking, a frank conversation with your prescriber at any plateau is always the right move before adjusting anything.
NICE's appraisal of semaglutide, TA875, recommends reviewing continuation if less than 5% of body weight has been lost after six months at the maintenance dose. That threshold exists to make sure people aren't staying on a medicine that isn't helping them. It's a clinical safety net, not an indication that most people fail.
Choosing a private prescription route, rather than waiting for NHS access through a specialist service, changes the speed of access. It doesn't change how the medicine works in your body. The titration schedule, the timeline to results, the side-effect profile, the need for a diet and lifestyle change alongside treatment: all of these remain the same regardless of who prescribes it.
What a regulated private service does change is clinical oversight. At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber before any prescription is issued, and every repeat order goes through the same clinical review. No subscriptions, no auto-renewals. If you'd like to understand how long until you start losing weight on Wegovy and what's included in the cost of private treatment, the weight-loss treatment overview sets that out clearly. The price of a private prescription should always include the clinical assessment; if it doesn't, that's worth questioning.
If you're thinking about starting and want to understand whether you'd be eligible, check your eligibility through a free consultation. A prescriber will review your circumstances the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.